Immunosuppression may mask severe infection. Septic arthritis in tocilizumab treatment yielded only modest acute-phase reaction
| Medienart: |
Artikel |
|---|
| Erscheinungsjahr: |
2012 |
|---|---|
| Erschienen: |
2012 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:109 |
|---|---|
| Enthalten in: |
Lakartidningen - 109(2012), 38 vom: 24. Sept., Seite 1678-9 |
| Sprache: |
Schwedisch |
|---|
| Weiterer Titel: |
Immunsuppression kan maskera allvarlig infektion. Septisk artrit under tocilizumabbehandling gav endast blygsam akutfasreaktion |
|---|
| Beteiligte Personen: |
Ljung, Lotta [VerfasserIn] |
|---|
| Themen: |
9007-41-4 |
|---|
| Anmerkungen: |
Date Completed 01.11.2012 Date Revised 25.11.2016 published: Print Citation Status MEDLINE |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
NLM222072938 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM222072938 | ||
| 003 | DE-627 | ||
| 005 | 20231224053421.0 | ||
| 007 | tu | ||
| 008 | 231224s2012 xx ||||| 00| ||swe c | ||
| 028 | 5 | 2 | |a pubmed24n0740.xml |
| 035 | |a (DE-627)NLM222072938 | ||
| 035 | |a (NLM)23094399 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a swe | ||
| 100 | 1 | |a Ljung, Lotta |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Immunosuppression may mask severe infection. Septic arthritis in tocilizumab treatment yielded only modest acute-phase reaction |
| 246 | 3 | 3 | |a Immunsuppression kan maskera allvarlig infektion. Septisk artrit under tocilizumabbehandling gav endast blygsam akutfasreaktion |
| 264 | 1 | |c 2012 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 500 | |a Date Completed 01.11.2012 | ||
| 500 | |a Date Revised 25.11.2016 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Case Reports | |
| 650 | 4 | |a Journal Article | |
| 650 | 7 | |a Antibodies, Monoclonal, Humanized |2 NLM | |
| 650 | 7 | |a Antirheumatic Agents |2 NLM | |
| 650 | 7 | |a Immunosuppressive Agents |2 NLM | |
| 650 | 7 | |a Receptors, Interleukin-6 |2 NLM | |
| 650 | 7 | |a C-Reactive Protein |2 NLM | |
| 650 | 7 | |a 9007-41-4 |2 NLM | |
| 650 | 7 | |a tocilizumab |2 NLM | |
| 650 | 7 | |a I031V2H011 |2 NLM | |
| 700 | 1 | |a Smeds, Johan |e verfasserin |4 aut | |
| 700 | 1 | |a Persson, Gunilla |e verfasserin |4 aut | |
| 700 | 1 | |a Jirlén, Lena |e verfasserin |4 aut | |
| 700 | 1 | |a Toolanen, Göran |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Lakartidningen |d 1965 |g 109(2012), 38 vom: 24. Sept., Seite 1678-9 |w (DE-627)NLM000007544 |x 1652-7518 |7 nnns |
| 773 | 1 | 8 | |g volume:109 |g year:2012 |g number:38 |g day:24 |g month:09 |g pages:1678-9 |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 109 |j 2012 |e 38 |b 24 |c 09 |h 1678-9 | ||